FENSOLVI KIT Drug Patent Profile
✉ Email this page to a colleague
When do Fensolvi Kit patents expire, and when can generic versions of Fensolvi Kit launch?
Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. There are two patents protecting this drug.
This drug has eleven patent family members in eleven countries.
The generic ingredient in FENSOLVI KIT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fensolvi Kit
A generic version of FENSOLVI KIT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FENSOLVI KIT?
- What are the global sales for FENSOLVI KIT?
- What is Average Wholesale Price for FENSOLVI KIT?
Summary for FENSOLVI KIT
International Patents: | 11 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FENSOLVI KIT |
DailyMed Link: | FENSOLVI KIT at DailyMed |
Pharmacology for FENSOLVI KIT
Drug Class | Gonadotropin Releasing Hormone Receptor Agonist |
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Agonists |
US Patents and Regulatory Information for FENSOLVI KIT
FENSOLVI KIT is protected by two US patents.
Patents protecting FENSOLVI KIT
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FENSOLVI KIT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | ⤷ Sign Up | ⤷ Sign Up |
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | ⤷ Sign Up | ⤷ Sign Up |
Tolmar | FENSOLVI KIT | leuprolide acetate | POWDER;SUBCUTANEOUS | 213150-001 | May 1, 2020 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FENSOLVI KIT
See the table below for patents covering FENSOLVI KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 1126822 | ⤷ Sign Up | |
Japan | 6087886 | ⤷ Sign Up | |
Australia | 2001292931 | ⤷ Sign Up | |
Japan | 2014240439 | 改良された効力を備えた、ロイプロリドのポリマー送達処方物 (POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY) | ⤷ Sign Up |
Czech Republic | 303134 | Polymerní formulace leuprolidu pro podání se zlepšenou úcinností (Leuprolide polymeric delivery formulation with improved efficacy) | ⤷ Sign Up |
New Zealand | 525210 | Polymeric delivery formulations of leuprolide with improved efficacy | ⤷ Sign Up |
Hong Kong | 1141459 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |